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Ultrastructural Changes, Nuclear Factor-κB Activation, and Tumor Necrosis 
Factor-α Expression in Brain after Acute Normovolemic Hemodilution and 
Controlled Hypotension in Rats
Aim To examine brain damage following different degrees of acute 
normovolemic hemodilution combined with controlled hypotension 
(ANH-CH) by neuronal morphological analysis and investigate the ex-
pression of nuclear factor-kappa B (NF-κB) activity and tumor necrosis 
factor-alpha (TNF-α) in the rat.
Methods Forty rats were randomly assigned to receive a sham opera-
tion or ANH-CH (with hematocrit 30%, 25%, 20%, and 15%). ANH 
was performed after baseline physiological parameters had been moni-
tored for 20 minutes. CH was induced 30 minutes later using sodium 
nitroprusside and mean arterial pressure was maintained at 50-60 mm 
Hg for 1 hour. Rats were euthanatized 3 and a half hours after opera-
tion. TNF-α levels and NF-κB activities in cerebral temporal cortex 
were measured. Ultrastructural alterations in the CA1 region of the rat 
hippocampi were observed. Changes in mitochondria were evaluated 
semiquantitatively.
Results Marked ultrastructural alterations, such as mitochondrial de-
naturalization and nucleus distortion, were observed in the CA1 re-
gion of the hippocampus in the ANH-CH hematocrit 20% group and 
ANH-CH hematocrit 15% group. TNF-α expression and NF-κB activ-
ity in the cerebral temporal cortex significantly increased in all ANH-
CH groups and peaked in the ANH-CH hematocrit 25% group.
Conclusion Severe ANH-CH with hematocrit ≤20% may induce ce-
rebral damage and should be avoided. NF-κB activation and TNF-α 
expression may play a functional role under the ischemic condition. A 
better understanding of the role of NF-κB and TNF-α in the brain may 
lead to a novel approach for preventing and treating various neurologi-
cal disorders.
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Evidence suggests that restrained blood trans-
fusion is associated with a low risk of mor-
bidity and mortality, even in the elderly and 
critically ill patients (1). Both acute normo-
volemic hemodilution (ANH) and controlled 
hypotension (CH) have independently dem-
onstrated their efficacy as blood-saving tech-
niques (2,3). Consequently, their combina-
tion could produce an even better method for 
blood conservation. However, the combined 
use of ANH and CH is still underutilized, be-
cause of concerns that reduced oxygen con-
tent and perfusion pressure may lead to isch-
emic and hypoperfusion injury to vital organs 
(4). The vital organ most susceptible to hy-
poxia is the brain. It has high oxygen demand 
and exclusive dependence on glucose oxida-
tion, which necessitates a tight control system 
for cerebral blood flow. ANH can increase ce-
rebral blood flow to compensate for decreased 
arterial oxygen content (5), but ANH in com-
bination with CH reduces the increased ce-
rebral blood flow (4). Therefore, care must be 
taken to avoid brain damage when this com-
bined technique is used.
Nuclear factor-kappa B (NF-κB) is a tran-
scription factor expressed in all cell types in 
the nervous system. It can be activated by 
many different physiological stimuli. Previ-
ous studies have shown that NF-κB could ac-
tivate gene expression in response to ischemia, 
which plays a pivotal role in neuronal survival 
(6). However, it has been reported that NF-κB 
activation may be associated with apoptotic or 
necrotic cell death (7).
Tumor necrosis factor-α (TNF-α) is a mul-
tifunctional cytokine that may play an impor-
tant role both in normal central nervous sys-
tem development and in the response of the 
brain to diverse forms of injury (8). Recent 
data suggest that it may be synthesized and se-
creted by several central nervous system cell 
types including microglia, astrocytes, and neu-
rons. Some authors consider that TNF-α may 
be of extreme benefit in repair and regenera-
tion of brain ischemic injury (9). On the oth-
er hand, data also show that it may be an im-
portant mediator in neuronal apoptosis (10). 
However, no previous studies have evaluated 
whether ANH-CH stimulates TNF-α expres-
sion or NF-κB activation in the brain of rats. 
To address this question, we aimed to deter-
mine whether ANH-CH causes cerebral hy-
poxia and to evaluate the role of NF-κB and 
TNF-α in the brain ischemic injury following 
ANH-CH.
Material and methods
Animals and experimental protocol
Adult male Sprague-Dawley rats (350-400 
g; Shanghai Animal Center, Shanghai, Chi-
na) were kept in accordance with the Institu-
tional Animal Care Committee guidelines in 
a room with a temperature of 22°C and a 12-
hour light/dark cycle. Animals were allowed at 
least 7 days to acclimatize before experiments. 
They were anaesthetized by intraperitoneal ad-
ministration of 1250 mg/kg urethane (Shang-
hai Chemical Reagent Co, Shanghai, China), 
intubated, and mechanically ventilated with a 
volume-control mode (tidal volume 8 mL/kg, 
frequency 60 bpm, FiO2 1.0). From blood-gas 
analysis (Radiometer ALB 500, London Sci-
entific, London, UK), ventilation parameters 
were adjusted to maintain arterial oxygen sat-
uration (SaO2) greater than 95% and PaCO2 
within a normal physiological range.
The tail vein was cannulated with a poly-
ethylene catheter for intravenous adminis-
tration of solutions. The macrohemodynam-
ic parameters including mean arterial blood 
pressure (MAP), heart rate (HR), and central 
venous pressure (CVP) were measured on the 
left femoral artery and vein, which were cath-
eterized with a microtip transducer (Abbot 
Laboratories Ltd, Chicago, IL, USA).
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Forty male rats were randomly divided into 
5 treatment groups (8 rats per group) – sham-
operated group and four groups with different 
degrees of ANH-CH (hematocrit 30%, 25%, 
20%, and 15%). After 20 minutes of monitor-
ing of baseline parameters, ANH was accom-
plished by withdrawal of blood from the fem-
oral artery and simultaneous administration 
of equivalent volume of hydroxyethyl starch 
(130/0.4, 6%; medium molecular weight, low 
degree of substitution; Fresenius Kabi, Bad 
Homburg, Germany) through the tail vein at 
the same rate. To reach different hematocrit 
targets, the volume (V) of blood to be removed 
was calculated as follows (11): V = EBV × (Hi-
Hf)/Hav, where EBV is the estimated blood 
volume (70 mL/kg), Hi the initial hematocrit, 
Hf the final hematocrit after ANH, and Hav 
mean hematocrit (mean of Hi and Hf). Thirty 
minutes after ANH, CH was induced with in-
fusion of 0.01% sodium nitroprusside at 0.15-
15 μg kg-1min-1 to decrease MAP to 50-60 mm 
Hg in 5 minutes and maintain for 1 hour. The 
sham-operated group was anesthetized and 
underwent the same anesthetic and surgical 
technique, but without ANH and CH. MAP, 
HR, CVP, and arterial blood gas were record-
ed immediately before hemodilution (T0), just 
before CH (T1), in the middle of controlled 
hypotension (T2), at the end of CH (T3), and 
30 minutes after recovery from CH (T4) (Fig-
ure 1). After operation lasting for 3.5 hours, 
animals were sacrificed by an overdose of ure-
thane. During the experiment, a heating pad 
and heating lamp were used to maintain the 
rectal temperature of rats at about 37°C. The 
total doses of sodium nitroprusside did not 
differ among the treated groups, and the need 
for additional doses of urethane used to kill 
the rats was similar. The study protocols were 
approved by the Institutional Animal Care 
Committee of Sir Run Run Shaw Hospital.
Histological and ultrastructural studies
With the animals still anesthetized, systemic 
circulation was perfused with 0.9% saline. The 
cerebral cavity of rats was carefully opened, the 
hippocampus was immediately removed, and 
a 500-μm block (measured along the pyrami-
dal cell body layer) of area CA1 was dissected 
and fixed for 48 hours in Somogyi’s solution 
of paraformaldehyde, glutaraldehyde 25%, and 
picric acid (pH 7.4) for electron microscopy 
(12). The tissue was dehydrated in ethanol and 
embedded in epoxy resin for ultrastructural 
studies.
Changes in mitochondria were evaluated 
semiquantitatively (13,14), whereas changes 
in other cell organelles and components were 
simply described. Electron micrographs were 
taken of each of the five biopsies, and in each 
micrograph 20 mitochondria were selected at 
random. Each mitochondrion was graded on 
a scale of 0 to 3, as follows: 0 – normal struc-
ture (Figure 2A); 1 – a little change but clear 
crests (Figure 2B); 2 – edematous change (Fig-
ure 2C); 3 – accumulation of amorphous ma-
terial (Figure 2D).
Determination of cerebral cortex cytokine levels
Cerebral temporal cortex tissues were homog-
enized in extract buffer (0.32 mol/L sucrose, 1 
mmol/L EDTA, 5 mmol/L Tris [pH 7.4], 0.1 
mmol/L phenylmethylsulfonyl fluoride, 10 
μmol/L leupeptin, and 1 mmol/L β-mercapto-
ethanol),  and 0.1% (wt/vol) proteinase inhibi-
tor. Each homogenate was centrifuged at 1000 
g for 10 minutes and the pellet was discarded. 
The supernatant was centrifuged at 160 000 
rpm for 30 minutes and the supernatant col-
lected (15). All procedures were performed at 
Figure 1. Definition of study time points. O – operation, S – animals 
were sacrificed, T0 – immediately before hemodilution, T1 – immedi-
ately before controlled hypotension, T2 – in the middle of controlled 
hypotension, T3 – at the end of controlled hypotension, T4 – 30 min-
utes after recovery from controlled hypotension.
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4°C. Protein concentrations were determined 
by Bradford assay. The samples were kept fro-
zen at -70°C until assay. The levels of TNF-α 
in cerebral temporal cortex tissue were quan-
tified using enzyme-linked immunosorbent as-
say (ELISA) kits specific for the rat cytokines, 
according to the manufacturer’s instructions 
(Diaclone Research, Besancon, Cedes, France). 
Each measurement was performed in duplicate 
according to the manufacturer’s recommenda-
tions and the averages were reported. Values 
were expressed as pg/mg protein.
Determination of cerebral cortex NF-κB activities 
by EMSA
The nuclear extracts were prepared from 
about 100 mg cerebral cortex tissue accord-
ing to a method established by our labora-
tory (16) and kept at -70°C for electropho-
retic mobility shift assay (EMSA). Protein 
concentrations were determined using Brad-
ford protein assay formats. EMSA was per-
formed using a commercial kit Gel Shift As-
say System (Promega, Madison, WI, USA). 
NF-κB consensus oligonucleotide (5′-AGTT-
GAGGGGACTTTCCCAGGC-3′) was la-
beled with [γ-32P] ATP (Free Biotech, Beijing, 
China) with T4 polynucleotide kinase. Equal 
amounts of nuclear extract (80 µg) were add-
ed to 9 µL of gel shift binding buffer (Tris-
HCl 10 mmol/L [pH 7.5], NaCl 50 mmol/L, 
EDTA 0.5 mmol/L, MgCl2 1 mmol/L, DTT 
0.5 mmol/L, 4% glycerol, 0.05 g/L Poly dIdC; 
15 minutes, room temperature). The mixture 
was incubated for 30 minutes with 1 µL of the 
32P-labeled oligonucleotide probe. One micro-
liter of loading buffer was added to stop the re-
action and the sample was electrophoresed in 
a 4% polyacrylamide gel. The dried gel was ex-
posed to x-ray film (Fuji Hyperfilm) at -70°C. 
The intensity of the NF-κB complex was quan-
tified by densitometry.
Statistical analysis
Data are presented as mean ± standard devia-
tion (SD). Analyses were performed by Statis-
tical Package for the Social Sciences, version 
11.0 (SPSS Inc., Chicago, IL, USA). Differ-
ences among groups were determined by one-
way analysis of variance (ANOVA), followed 
by the least-significant-difference (LSD) post 
hoc test. Significant differences within groups 
by time as compared with the baseline were 
tested by the repeated measures analysis. Dif-
ferences were considered statistically signifi-
cant if P<0.05.
Results
Effect of ANH-CH on macrohemodynamics and 
arterial blood gas parameters
MAP, HR, and CVP were similar in all 
groups at baseline. MAP and HR did not dif-
fer between T0 and T1 in any group. With 
ANH-CH, HR was increased at T2 and T3, 
and MAP was lower at T4 than at baseline. 
Throughout the experiment, CVP was stable. 
PaO2 and PaCO2 were within the reference 
range at all time points, but pH decreased sig-
Figure 2. Postulated stages of mitochondrial reaction in CA1 region 
of rat hippocampus following acute normovolemic hemodilution com-
bined with controlled hypotension. (A) mitochondrial score 0 – normal 
structure. (B) score 1 – a little change but clear crests. (C) score 2 
– edematous change. (D) score 3 – accumulation of amorphous mate-
rial. Arrows indicate the respective mitochondria.
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nificantly at T3 (P = 0.007 vs baseline) and T4 
(P = 0.011 vs baseline; P = 0.038 vs sham-oper-
ated group) in the ANH-CH hematocrit 15% 
group (Table 1).
Effect of ANH-CH on ultrastructural changes in the 
hippocampus
ANH-CH hematocrit 20% group and ANH-
CH hematocrit 15% group showed uniform 
alterations in the cerebral ultrastructure. Mean 
mitochondrial scores in the two groups were 
significantly higher than in the sham-operated 
group (P = 0.003; P < 0.001) (Figure 3). Most 
nuclei appeared normal in the sham-operat-
ed (Figure 4A), ANH-CH hematocrit 30% 
Table 1. Effect of acute normovolemic hemodilution combined with controlled hypotension (ANH-CH) on macrohemodynamic param-
eters and arterial blood gas measurements in rats
Time point
Variable (mean±SD) T0 T1 T2 T3 T4
Mean arterial pressure (mm Hg):
 sham  109 ± 9  110 ± 8  106 ± 8  108 ± 6  105 ± 7*
 ANH-CH hematocrit 30%  115 ± 9  115 ± 6   56 ± 6   60 ± 4   95 ± 4†‡*
 ANH-CH hematocrit 25%  109 ± 9  109 ± 9   54 ± 5   57 ± 8   93 ± 4†‡
 ANH-CH hematocrit 20%  105 ± 8  108 ± 7   56 ± 5   58 ± 5   89 ± 5†‡
 ANH-CH hematocrit 15%  112 ± 10  114 ± 6   56 ± 6   55 ± 4   86 ± 4†‡
Heart rate (beats/min):
 sham  348 ± 18  347 ± 15  342 ± 15*  339 ± 13*  340 ± 17
 ANH-CH hematocrit 30%  342 ± 19  352 ± 9  369 ± 12†  365 ± 10†‡  344 ± 13
 ANH-CH hematocrit 25%  350 ± 17  350 ± 14  375 ± 13†‡  378 ± 12†‡  341 ± 12
 ANH-CH hematocrit 20%  352 ± 38  355 ± 14  382 ± 22†‡  379 ± 19†‡  350 ± 17
 ANH-CH hematocrit 15%  349 ± 14  347 ± 11  380 ± 20†‡  377 ± 16†‡  351 ± 16
Central venous pressure (mmHg):
 sham 7.13 ± 0.83 7.25 ± 0.71 7.63 ± 0.52 7.24 ± 0.48 7.13 ± 0.64
 ANH-CH hematocrit 30% 6.69 ± 1.06 7.00 ± 0.76 7.00 ± 0.76 7.13 ± 0.54 6.38 ± 0.52
 ANH-CH hematocrit 25% 6.63 ± 1.07 6.75 ± 1.28 6.78 ± 1.07 6.70 ± 0.62 6.18 ± 0.83
 ANH-CH hematocrit 20% 6.75 ± 1.13 7.00 ± 1.07 6.75 ± 1.04 6.95 ± 0.98 6.35 ± 1.25
 ANH-CH hematocrit 15% 6.50 ± 0.93 6.65 ± 0.70 6.75 ± 1.05 6.48 ± 0.89 6.28 ± 1.0
PaO2 (kPa):
 sham 42.8 ± 2.4 43.9 ± 2.3 44.0 ± 2.1 44.4 ± 1.9 45.5 ± 1.9
 ANH-CH hematocrit 30% 43.5 ± 2.1 43.1 ± 2.0 42.5 ± 2.0 42.8 ± 1.7 44.0 ± 1.7
 ANH-CH hematocrit 25% 42.1 ± 2.8 42.0 ± 2.0 41.3 ± 1.3 41.6 ± 2.1 43.1 ± 2.7
 ANH-CH hematocrit 20% 42.8 ± 3.3 43.7 ± 2.8 42.5 ± 2.1 42.1 ± 2.8 45.3 ± 2.
 ANH-CH hematocrit 15% 42.5 ± 2.5 42.4 ± 2.7 41.6 ± 2.7 41.3 ± 2.1 43.7 ± 2.1
PaCO2 (kPa):
 sham  5.6 ± 0.4  5.5 ± 0.3  5.2 ± 0.5  5.1 ± 0.4  5.3 ± 0.5
 ANH-CH hematocrit 30%  5.1 ± 0.4  5.1 ± 0.5  4.9 ± 0.4  5.2 ± 0.5  5.3 ± 0.7
 ANH-CH hematocrit 25%  5.5 ± 0.3  5.5 ± 0.4  5.3 ± 0.4  5.1 ± 0.5  5.2 ± 0.5
 ANH-CH hematocrit 20%  5.2 ± 0.3  5.2 ± 0.4  5.3 ± 0.7  5.5 ± 0.4  5.2 ± 0.4
 ANH-CH hematocrit 15%  5.6 ± 0.5  5.3 ± 0.3  5.2 ± 0.4  5.3 ± 0.5  5.5 ± 0.8
Acidity:
 sham 7.38 ± 0.05 7.40 ± 0.04 7.39 ± 0.05 7.40 ± 0.08 7.39 ± 0.03*
 ANH-CH hematocrit 30% 7.39 ± 0.04 7.39 ± 0.03 7.38 ± 0.06 7.40 ± 0.07 7.41 ± 0.06*
 ANH-CH hematocrit 25% 7.40 ± 0.05 7.41 ± 0.02 7.37 ± 0.05 7.36 ± 0.05 7.39 ± 0.05*
 ANH-CH hematocrit 20% 7.41 ± 0.06 7.42 ± 0.03 7.35 ± 0.03 7.34 ± 0.06 7.38 ± 0.06
 ANH-CH hematocrit 15% 7.42 ± 0.05 7.40 ± 0.04 7.32 ± 0.04 7.28 ± 0.07† 7.29 ± 0.05†‡
*P<0.05 vs ANH-CH hematocrit 15%.
†P<0.05 vs baseline.
‡P<0.05 vs sham-operated group.
Figure 3. Ultrastructural mitochondrial scores of hippocampal neu-
rons in CA1 region following acute normovolemic hemodilution 
combined with controlled hypotension (ANH-CH). S – sham-oper-
ated group; 30% – ANH-CH hematocrit 30% group; 25% – ANH-CH 
hematocrit 25% group; 20% – ANH-CH hematocrit 20% group; 15% 
– ANH-CH hematocrit 15% group. Values are presented as mean±SD. 
Asterisk indicates P<0.01 vs sham-operated group at the end of the 
experiment.
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(Figure 4B), and ANH-CH hematocrit 25% 
group (Figure 4C). Margination and clump-
ing of chromatin were seen occasionally in the 
ANH-CH hematocrit 20% group, but more 
frequently in the ANH-CH hematocrit 15% 
group. Nuclear membrane was slightly irreg-
ular in the ANH-CH hematocrit 20% group 
(Figure 4D) and became more irregular in the 
ANH-CH hematocrit 15% group (Figure 4E). 
Glial activation, such as swollen glia assem-
bling around the neurons, could be seen in the 
ANH-CH hematocrit 20% (Figure 4F) and 
ANH-CH hematocrit 15% group (Figure 4G).
Effect of ANH-CH on the level of TNF-α and activity 
of NF-κB in the cerebral cortex
Compared with the sham-operated group 
(6.4 ± 0.3 pg/mg protein), ANH-CH in other 
groups of rats was associated with a significant 
increase in TNF-α levels in the cerebral cor-
tex tissue (ANH-CH hematocrit 30% group 
8.5 ± 0.5 pg/mg protein [P<0.001], ANH-CH 
hematocrit 25% group 11.6 ± 0.6 pg/mg pro-
tein [P<0.001], ANH-CH hematocrit 20% 
group 8.2 ± 0.4 pg/mg protein [P = 0.001], 
ANH-CH hematocrit 15% group 7.8 ± 0.5 
pg/mg protein [P = 0.005]), which achieved 
the maximum in the ANH-CH hemato-
crit 25% group (P<0.001 vs the other three 
groups) (Figure 5). Changes in cerebral activi-
ties of NF-κB were parallel to those in TNF-α 
levels. The NF-κB activity was expressed as the 
ratio between the photodensity of NF-κB and 
the photodensity of the background. In the 
four treatment groups, cerebral cortical NF-κB 
Figure 4. Nuclear changes in CA1 region of rat hippocampus after 
acute normovolemic hemodilution combined with controlled hypoten-
sion (ANH-CH). (A) Ultrastructure of representative nucleus in CA1 
region of hippocampus in sham-operated group; (B) ultrastructure 
of representative nuclei in CA1 region of hippocampus in ANH-CH 
hematocrit 30% group; (C) ultrastructure of representative nuclei in 
CA1 region of hippocampus in ANH-CH hematocrit 25% group; (D) 
ultrastructure of representative nuclei in CA1 region of hippocampus 
in ANH-CH hematocrit 20% group; (E) ultrastructure of representa-
tive nuclei in CA1 region of hippocampus in ANH-CH hematocrit 15% 
group; (F) glial alteration (black arrow) in ANH-CH hematocrit 20% 
group; and (G) glial alteration (black arrow) in ANH-CH hematocrit 
15% group.
Figure 5. Effect of acute normovolemic hemodilution combined with 
controlled hypotension (ANH-CH) on tumor necrosis factor-a (TNF-a) 
level in the cerebral cortex tissue. S – sham-operated group; 30% 
– ANH-CH hematocrit 30% group; 25% – ANH-CH hematocrit 25% 
group; 20% – ANH-CH hematocrit 20% group; 15% – ANH-CH hema-
tocrit 15% group. Values are presented as mean±SD. Asterisk indi-
cates P<0.01 vs sham-operated group, and string indicates P<0.001 
vs ANH-CH hematocrit 30% group, ANH-CH hematocrit 20% group, 
and ANH-CH hematocrit 15% group.
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activity increased to 6.04 ± 0.52 (ANH-CH 
hematocrit 30% group; P<0.001), 8.62 ± 0.32 
(ANH-CH hematocrit 25% group; P<0.001), 
5.26 ± 0.38 (ANH-CH hematocrit 20% 
group; P = 0.001), and 4.86 ± 0.41 (ANH-CH 
hematocrit 15% group; P = 0.008) relative 
units, respectively, compared with 3.84 ± 0.21 
in the sham-operated group, and the ANH-
CH hematocrit 25% group had a significant-
ly higher level than the other three groups 
(P<0.001; Figure 6).
Discussion
In our study, ANH-CH with low hematocrit 
(≤20%) caused cerebral hypoxic-ischemic inju-
ry in rats. It was also associated with increased 
NF kB activity and TNF-a level in the cerebral 
cortex.. These data provide experimental evi-
dence that ANH-CH with hematocrit ≤20% 
should be avoided.
ANH and CH are independently effective 
in decreasing operative blood loss and trans-
fusion of allogeneic blood (2,3). Their com-
bination may further reduce the need for al-
logeneic blood transfusion (17,18). However, 
, a confirmed safe limit of ANH-CH has not 
been reported, and blood-sparing benefits of 
the combination must be weighed against the 
risk of inadequate tissue oxygenation (17).
In our study, ANH-CH did not cause se-
rious hemodynamic instability. HR increased 
only moderately during CH, which might 
be a compensation mechanism for decreased 
blood pressure. In addition, at T4, the point 
of recovery after CH, MAP was lower than at 
baseline in all treatment groups, possibly be-
cause of hydroxyethyl starch 130/0.4 decreas-
ing blood volume expansion, which occurred 
2 hours after the infusion of hydroxyethyl 
starch. PaO2 did not differ from baseline lev-
els during ANH-CH but showed a decreasing 
trend, especially in the ANH-CH hematocrit 
15% group, which might result in the de-
creased pH. In addition, tissue hypoperfusion 
induced by CH might be another explanation 
for the decreased pH.
Hippocampal CA1 neurons are highly sus-
ceptible to short periods of transient global 
ischemia (7). We showed their significant al-
teration, verified with electron microscopy in 
rats hemodiluted to very low levels of hemato-
crit. Cerebral histological investigation of hip-
pocampal CA1 neurons with electron micros-
copy revealed characteristic morphological 
damage, such as mitochondria denaturaliza-
tion, nucleus distortion, and astroglial activa-
tion in severe ANH-CH (hematocrit ≤20%). 
It is clear that significant alterations in mito-
chondrial structure quickly occur in severely 
ischemic tissue (13). Also, several typical ul-
trastructural alterations in neurons, such as 
disruption of mitochondrial cristae, severe 
damage to mitochondrial membrane, and 
clumping and margination of chromatin in the 
Figure 6. Effect of acute normovolemic hemodilution combined with 
controlled hypotension (ANH-CH) on nuclear factor-kappa B (NF-κB) 
activity in cerebral cortex tissue. Lane 1 – sham-operated group; Lane 
2 – ANH-CH hematocrit 30% group; Lane 3 – ANH-CH hematocrit 
25% group; Lane 4 – ANH-CH hematocrit 20% group; Lane 5 – ANH-
CH hematocrit 15% group; S – sham-operated group; 30% – ANH-CH 
hematocrit 30% group; 25% – ANH-CH hematocrit 25% group; 20% 
– ANH-CH hematocrit 20% group; and 15% – ANH-CH hematocrit 15% 
group. Values are presented as mean±SD. Asterisk indicates P<0.01 
vs sham-operated group, and string indicates P<0.001 vs ANH-CH 
hematocrit 30% group, ANH-CH hematocrit 20% group, and ANH-CH 
hematocrit 15% group.
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nuclei are related to irreversible neuronal inju-
ry (13). Similarly, we concluded that cerebral 
tissue was exposed to hypoxic-ischemic inju-
ry in ANH-CH with low hematocrit (≤20%), 
which might have resulted from the combined 
reduction of oxygen-carrying capacity and per-
fusion pressure in the brain.
NF-κB in the brain is activated by various 
intercellular signals, including cytokines, neu-
rotrophic factors, and neurotransmitters. In 
this study, NF-κB activities were increased in 
the cerebral cortex in rats treated with ANH-
CH and reached the highest level in hemato-
crit 25% group, while the ultrastructural study 
of brain showed no obvious changes. For 
ANH with extremely low hematocrit groups, 
up-regulated activities of NF-κB were sup-
pressed. Previous studies have shown that NF-
κB is important for the induction of neuropro-
tective anti-apoptotic gene products such as 
MnSOD and Bcl-2, which are known to con-
tribute to ischemic tolerance (6). In contrast 
to the anti-apoptosis action of NF-κB, Clem-
ens et al (7) have reported that transient fore-
brain ischemia resulted in a marked activation 
of NF-κB in the highly vulnerable CA1 sector, 
which may be associated with apoptotic or ne-
crotic cell death. Xu et al (19) have indicated 
that acute inhibition of NF-κB activation re-
duced brain injury in a rat model of middle ce-
rebral artery occlusion. Our results may sug-
gest that hypoxia at doses close to but below 
the threshold of cell injury induce NF-κB acti-
vation as an adaptive response. While hypoxia 
reaches the threshold, NF-κB activities may be 
attenuated because of brain resident cells in-
jury. We could not define whether NF-κB ac-
tivation serves as a neuroprotective process or 
not. The exact role of NF-κB in brain ischemic 
injury remains to be explored.
Recent data suggest that several inflamma-
tory cytokines may be synthesized and secret-
ed by several central nervous system cell types 
including microglia, astrocytes, and neurons 
(20). These cytokines could influence both 
progression of injury and regulation of wound 
healing in the brain. In our study, TNF-α lev-
els in the cerebral cortex were elevated in all 
ANH-CH groups as early as 3 hours after 
ANH-CH, peaking in the ANH-CH hemato-
crit 25% group. These results support the hy-
pothesis that cytokines play a functional role 
in the acute post-ischemic period. The turning 
point of TNF-α may suggest that brain damage 
would happen if severe ANH-CH (hematocrit 
≤20%) was performed. Some authors consider 
that TNF-α and other cytokines may be of ex-
treme benefit and exert key roles in repair and 
regeneration of the injured brain tissue. TNF-
α has been shown to act in a synergistic man-
ner with interleukin (IL)-1β to produce nerve 
growth factor (9) and prevent metabolic con-
sequences of glucose deprivation in cultured 
cortical, septal, and hippocampal neurons 
(21). The vulnerability of cortical and striatal 
neurons to focal ischemic injury are increased 
in mice lacking TNF-α receptors (22,23). On 
the other hand, data also show that TNF-
α may be an important mediator in neuronal 
apoptosis in vivo as well as in neuronal loss as 
a result of brain injury (10,24). Neutralizing 
TNF-α activity by administration of TNF-α 
binding protein or antagonist attenuated brain 
ischemic injury (25,26). The functional role of 
cytokines in the brain injury is still controver-
sial. In our study, changes in cerebral activities 
of NF-κB were parallel with the production of 
TNF-α, which may indicate that TNF-α and 
NF-κB are both involved in the brain “homeo-
static” response to ischemic injury, and TNF-
α is a potential candidate for the role of NF-
κB activator.
In conclusion, our study indicated that so-
dium nitroprusside-induced CH did not re-
sult in cerebral injury with moderate ANH, 
but did so with severe hemodilution (hemato-
crit ≤20%) and that ANH-CH may result in 
cerebral hypoxic-ischemic injury, represent-
Croat Med J 2008;49:22-31
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ed by characteristic morphological damages in 
the CA1 region of the hippocampus. The com-
bination of severe ANH (hematocrit ≤20%) 
and CH should be avoided. Though the exact 
function of NF-κB and TNF-α in cerebral hy-
poxic-ischemic injury remains unclear, they 
may be important factors in brain tolerance in 
ischemic condition. Understanding how cyto-
kines and transcription factors regulate the re-
sponse to injury will facilitate the development 
of treatments for these injuries.
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Correction: Sefer et al: Effects of Renal Transplantation on Hearing and Ocular Changes in a Monozygotic Twin 
with Alport’s Syndrome: Comparison with Other Twin on Hemodialysis
To the Editor: In the article by Sefer et al “Effects of renal transplantation on hearing and ocular changes in 
a monozygotic twin with Alport’s syndrome: comparison with other twin on hemodialysis”, published in the 
Croatian Medical Journal (1), my last name was misspelled. As this misspelling causes problems with the retrieval 
of the articles I co-authored from bibliographical databases, the correct information on the article should be: Sefer 
S, Trotic R, Lacmanovic V, Degoricija V, Ratkovic-Gusic I, Kes P. Effects of renal transplantation on hearing and 
ocular changes in a monozygotic twin with Alport’s syndrome: comparison with other twin on hemodialysis. Croat 
Med J. 2000;41:203-6.
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